Correlation Between Aerovate Therapeutics and NRx Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and NRx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and NRx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and NRx Pharmaceuticals, you can compare the effects of market volatilities on Aerovate Therapeutics and NRx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of NRx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and NRx Pharmaceuticals.
Diversification Opportunities for Aerovate Therapeutics and NRx Pharmaceuticals
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between Aerovate and NRx is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and NRx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NRx Pharmaceuticals and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with NRx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NRx Pharmaceuticals has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and NRx Pharmaceuticals go up and down completely randomly.
Pair Corralation between Aerovate Therapeutics and NRx Pharmaceuticals
Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 0.26 times more return on investment than NRx Pharmaceuticals. However, Aerovate Therapeutics is 3.85 times less risky than NRx Pharmaceuticals. It trades about 0.11 of its potential returns per unit of risk. NRx Pharmaceuticals is currently generating about -0.09 per unit of risk. If you would invest 245.00 in Aerovate Therapeutics on September 1, 2024 and sell it today you would earn a total of 18.00 from holding Aerovate Therapeutics or generate 7.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 80.95% |
| Values | Daily Returns |
Aerovate Therapeutics vs. NRx Pharmaceuticals
Performance |
| Timeline |
| Aerovate Therapeutics |
| NRx Pharmaceuticals |
Aerovate Therapeutics and NRx Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aerovate Therapeutics and NRx Pharmaceuticals
The main advantage of trading using opposite Aerovate Therapeutics and NRx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, NRx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NRx Pharmaceuticals will offset losses from the drop in NRx Pharmaceuticals' long position.| Aerovate Therapeutics vs. Tff Pharmaceuticals | Aerovate Therapeutics vs. Eliem Therapeutics | Aerovate Therapeutics vs. Inhibrx | Aerovate Therapeutics vs. Enliven Therapeutics |
| NRx Pharmaceuticals vs. Tff Pharmaceuticals | NRx Pharmaceuticals vs. Eliem Therapeutics | NRx Pharmaceuticals vs. Inhibrx | NRx Pharmaceuticals vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |